Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PAHC - Phibro Animal Health Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$49.00
DETAILS
HIGH:
$49.00
LOW:
$49.00
MEDIAN:
$49.00
CONSENSUS:
$49.00
UPSIDE:
43.97%
Stock News
PAHC or LZAGY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?
Implied Volatility Surging for Phibro Animal Health Stock Options
Investors need to pay close attention to PAHC stock based on the movements in the options market lately.
Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Phibro (PAHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PAHC vs. SYK: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
What Makes Phibro (PAHC) a New Buy Stock
Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
This animal health provider, serving global livestock markets, reported a notable insider buy in its latest SEC filing.
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Implied Volatility Surging for Phibro Stock Options
Investors need to pay close attention to PAHC stock based on the movements in the options market lately.
Phibro Animal Health Corp (PAHC) Shares Fall 3.1% -- GF Value Says Still Overvalued
On May 28, 2026, Phibro Animal Health Corp (PAHC) shares fell 3.1% today, closing at $31.83. The stock has experienced significant volatility, trading between a
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 27, 2026, at 9:45 AM ET at Lotte New York Palace in New York. The live audio presentation will be available on the.
PAHC or SYK: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks is more attractive to value investors?
Phibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Phibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Deciphering Phibro (PAHC) International Revenue Trends
Review Phibro's (PAHC) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Phibro Animal Health Corporation (PAHC) Q3 2026 Earnings Call Transcript
Phibro Animal Health Corporation (PAHC) Q3 2026 Earnings Call Transcript
Price Targets
Phibro Animal Health price target raised to $49 from $45 at Morgan Stanley
$49.00
(was $53.66)
Morgan Stanley
Phibro Animal Health price target raised to $34 from $26 at Morgan Stanley
$34.00
(was $38.46)
Morgan Stanley
Phibro Animal Health price target raised to $26 from $21 at Morgan Stanley
$26.00
(was $24.75)
Morgan Stanley
Phibro Animal Health price target lowered to $20 from $27 at Morgan Stanley
$20.00
(was $16.81)
Erin Wright
·
Morgan Stanley
Roth Capital Initiates Coverage On Phibro Animal Health with Buy Rating, Announces Price Target of $18
$18.00
(was $12.75)
Roth Capital
Barclays Maintains Underweight on Phibro Animal Health, Lowers Price Target to $17
$17.00
(was $14.29)
Barclays
Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Lowers Price Target to $21
$21.00
(was $16.06)
Morgan Stanley